Medicare Part D coverage · estradiol · RxCUI 890918
estradiol 0.1 MG/ML Vaginal Cream [Estrace]
Per the CMS 2026 Part D formulary file, estradiol 0.1 MG/ML Vaginal Cream [Estrace] is covered by 118 Medicare Part D plans (2.3% of enrollable products), averaging Tier 1.5, with prior authorization required on 0% of covering formularies.
- 2.3%
- Plan coverage
- 118
- Plans covering
- T1.5
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for estradiol 0.1 MG/ML Vaginal Cream [Estrace]
Per the CMS 2026 Part D formulary file, estradiol 0.1 MG/ML Vaginal Cream [Estrace] (RxNorm concept RXCUI 890918, generic name estradiol) appears on 4 distinct formulary files spanning 118 Medicare Part D plan offerings - 2.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 2, with a cross-plan average of Tier 1.5.
Real-world access to estradiol 0.1 MG/ML Vaginal Cream [Estrace] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,289,816 Part D beneficiaries filled estradiol 0.1 MG/ML Vaginal Cream [Estrace] in 2023, with total plan-and-beneficiary spending of $239,028,017 and an average per-beneficiary annual cost of $185.32. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry estradiol 0.1 MG/ML Vaginal Cream [Estrace] today.
Coverage Details
- Formularies covering
- 4
- Plans covering
- 118
- Coverage rate
- 2.3%
- Tier range
- Tier 1 – Tier 2
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,289,816
- Total spending
- $239,028,017
- Avg per beneficiary
- $185.32
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering estradiol 0.1 MG/ML Vaginal Cream [Estrace]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is estradiol 0.1 MG/ML Vaginal Cream [Estrace] covered by Medicare Part D?
Yes, estradiol 0.1 MG/ML Vaginal Cream [Estrace] is covered by 118 Medicare Part D plans (2.3% of all Part D formularies).
What tier is estradiol 0.1 MG/ML Vaginal Cream [Estrace] on Medicare Part D plans?
estradiol 0.1 MG/ML Vaginal Cream [Estrace] averages Tier 1.5 across Part D plans, ranging from Tier 1 to Tier 2.
Does estradiol 0.1 MG/ML Vaginal Cream [Estrace] require prior authorization?
0% of Part D formularies require prior authorization for estradiol 0.1 MG/ML Vaginal Cream [Estrace]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on estradiol 0.1 MG/ML Vaginal Cream [Estrace]?
In 2023, total Medicare Part D spending on estradiol 0.1 MG/ML Vaginal Cream [Estrace] was $239,028,017, covering 1,289,816 beneficiaries. The average spend per beneficiary was $185.32.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- bisoprolol fumarate 2.5 MG / hydrochlorothiazide 6.25 MG Oral Tablet T1.5
- glycopyrrolate 1.5 MG Oral Tablet T1.5
- topiramate 50 MG Oral Tablet T1.5
- bisoprolol fumarate 10 MG / hydrochlorothiazide 6.25 MG Oral Tablet T1.5
- hydrocortisone 10 MG/ML Topical Cream T1.5
- amiodarone hydrochloride 200 MG Oral Tablet T1.5
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA